Subjective Quality of Life: Its Relationship with Clinician-Rated and Patient-Rated Psychopathology
Lasalvia A. · Ruggeri M. · Santolini N.
The South-Verona Outcome Project 6
Department of Medicine and Public Health, Section of Psychiatry, University of Verona, Verona, Italy
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Background: The study compared clinician-rated and patient-rated psychopathology and analysed their relationship with subjective quality of life (QoL) in a sample of patients with a wide range of psychiatric conditions attending a community-based mental health service. Methods: In the context of the South-Verona Outcome Project (SVOP), 139 patients were assessed for both clinician-rated and self-rated psychopathology (by using respectively the Brief Psychiatric Rating Scale and the revised version of the Symptom Checklist 90), and asked to report on their subjective quality of life (by using the Lancashire Quality of Life Profile). In order to explore the associations between psychopathology and subjective QoL bivariate and multivariate analyses were performed. Results: BPRS and SCL-90-R were poorly correlated, both in their total scores and in their various dimension scores. BPRS showed only a modest negative correlation with LQL, which, in contrast, was highly negatively correlated with SCL-90-R. Regression analyses showed that patient-rated psychopathology was the strongest predictor of subjective quality of life, with self-rated depressive symptoms and self-reported paranoid ideation having the highest predictive power. Conclusions: Self-reported psychological distress is more important than clinician-rated symptom severity in predicting subjective QoL. In order to improve QoL, psychiatric treatment should focus not only on simple reduction of symptoms but also on patients’ subjective psychological distress.
© 2002 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.